Abbott Laboratories

ABT(Abbott Laboratories)

$109.24-0.79%

ABT(Abbott Laboratories) Price Prediction Summary

AI-Generated
As of November 3, 2026, ABT is currently trading in the 103–104 range with a bullish technical backdrop. All moving averages are aligned long, MACD confirms momentum, and RSI is elevated but not yet extremes, suggesting the intermediate-term outlook remains favorable for buyers. However, overbought conditions and lack of sentiment or structural confirmation leave uncertainty about whether the rally can extend sustainably higher. Watch for RSI rejection above 70 and the 20-day MA as key decision points.
Technical Indicators
Short-Term Bullish

Daily trend is bullish; all three moving averages signal Buy, MACD positive, RSI elevated.

Key Trading Levels

How Gate Predicts ABT(Abbott Laboratories) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of November 3, 2026, ABT **stock technical analysis** shows a sustained uptrend with convergent bullish signals across the daily timeframe. The 20-day, 50-day, and 200-day moving averages are all generating Buy actions, indicating alignment of shorter-term momentum with intermediate and longer-term trend structure. MACD is trading at 1.3144 with a Buy signal, confirming positive momentum and the absence of bearish divergence. The Relative Strength Index sits at 65.1, placing the stock in elevated momentum territory without crossing into extreme overbought conditions \(typically 70+\), leaving room for further upside before exhaustion becomes a concern. The clustering of the moving averages in the 101–104 range, combined with the positive MACD level, suggests that the ABT price forecast remains constructive. Key variables to monitor include whether RSI can climb above 70 without rolling over immediately, and whether the price holds above the 20-day moving average as a critical support zone.
IndicatorValueSignal
Exponential Moving Average (10)105.7243
Buy
Exponential Moving Average (100)102.9886
Buy
Exponential Moving Average (20)104.2955
Buy
Exponential Moving Average (200)105.1767
Buy
Exponential Moving Average (30)103.8882
Buy
Exponential Moving Average (50)103.5711
Buy
Hull Moving Average (9)109.1685
Buy
Ichimoku Base Line (9, 26, 52, 26)102.8375
neutral
Moving Averages Summary—
neutral
Simple Moving Average (10)104.767
Buy
Simple Moving Average (100)102.2724
Buy
Simple Moving Average (20)103.3985
Buy
Simple Moving Average (200)101.5654
Buy
Simple Moving Average (30)102.2343
Buy
Simple Moving Average (50)104.065
Buy
Volume Weighted Moving Average (20)103.03
Buy
Average Directional Index (14)18.5375
neutral
Awesome Oscillator3.9249
neutral
Bull Bear Power9.3183
neutral
Commodity Channel Index (20)203.6599
Sell
MACD Level (12, 26)1.3052
Buy
Momentum (10)6.95
Buy
Oscillators Summary—
neutral
Relative Strength Index (14)64.7283
neutral
Stochastic %K (14, 3, 3)93.6785
neutral
Stochastic RSI Fast (3, 3, 14, 14)96.3273
neutral
Ultimate Oscillator (7, 14, 28)63.6472
neutral
Williams Percent Range (14)-9.3859
Sell
Technical Summary—
neutral

Market Sentiment

AI-GeneratedNo data yet
Analyst Rating
--
Options Put/Call Ratio
11.5100%
Implied Volatility (IV)
30.8989

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

FAQ

What data is used to generate the ABT(Abbott Laboratories) price prediction?

x

ABT(Abbott Laboratories) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the ABT(Abbott Laboratories) price prediction?

x

How are technical indicators used in the ABT(Abbott Laboratories) price prediction?

x

What role does market sentiment play in the ABT(Abbott Laboratories) price prediction?

x

What common factors can influence the ABT(Abbott Laboratories) price prediction?

x

How can price predictions be used to assess the current market state of ABT(Abbott Laboratories)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.